Research in the News: From curiosity to cancer drug: Yale researcher conquers ‘valley of death’

test test
(Illustration by Michael Helfenbein)

The fascination of Yale professor Craig Crews with a natural product compound led a decade later to the approval this summer of a brand-new treatment for multiple myeloma.

The story of how a novel kind of cancer drug, carfilzomib, was born from academic curiosity is the subject of a profile in Aug. 27 issue of the journal Chemical & Engineering News.

“This a great example of how university research can be translated into a medical therapy,” said Crews. “Too often promising ideas get lost in what drug companies call the valley of death.”

Share this with Facebook Share this with Twitter Share this with LinkedIn Share this with Email Print this

Media Contact

Bill Hathaway: william.hathaway@yale.edu, 203-432-1322